1122597-30-1

Basic information

• Product Name: tert-butyl {4-[(benzyloxy)amino]-4-oxobutyl}carbamate
• Synonyms: tert-butyl {4-[(benzyloxy)amino]-4-oxobutyl}carbamate
• CAS NO: 1122597-30-1
• Molecular Weight: 308.378
• Mol File: 1122597-30-1.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: tert-butyl {4-[(benzyloxy)amino]-4-oxobutyl}carbamate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl {4-[(benzyloxy)amino]-4-oxobutyl}carbamate(1122597-30-1)
• EPA Substance Registry System: tert-butyl {4-[(benzyloxy)amino]-4-oxobutyl}carbamate(1122597-30-1)

Safety Data

• Hazardous Substances Data: 1122597-30-1(Hazardous Substances Data)

Upstream product

• 2687-43-6 O-benzylhydoxylamine hydrochloride 
• 85909-08-6 tert-butyl 2-oxopyrrolidine-1-carboxylate 
• 57294-38-9 N-(tert-butoxycarbonyl)-4-aminobutanoic acid 
• 622-33-3 N-benzyloxyamine 

Downstream Products

• 1122597-34-5 4-amino-N-(benzyloxy)butanamide hydrochloride 
• 1414689-16-9 C₁₇H₂₆N₂O₄ 
• 1414689-24-9 C₁₂H₁₈N₂O₂*C₂HF₃O₂ 
• 1414689-39-6 C₁₃H₁₆N₂O₃ 
• 1414689-47-6 C₁₆H₂₅N₃O₄ 
• 1122748-09-7 C₁₁H₁₆N₂O₂ 

Relevant articles and documents

MDM2-HDAC double-target inhibitor, medicinal composition and preparation and application of MDM2-HDAC double-target inhibitor

The invention provides a MDM2-HDAC double-target inhibitor, a medicinal composition and preparation and application of the MDM2-HDAC double-target inhibitor. The MDM2-HDAC double-target inhibitor hasa structure as shown in formula I. The inhibitor with th

HDAC INHIBITORS

The present invention provides hydroxamic acid compounds, and methods of preparation of these compounds. The present invention also relates to pharmaceutical compositions comprising the hydroxamic acid compounds. The present invention provides methods of treating a cell proliferative disorder, such as a cancer, by administering to a subject in need thereof a therapeutically effective amount of a compound of the present invention.